All In Biotech

Drug Trial Radar · NCT00204685

Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa

Beatmungsdauer Und Lungenfunktion Bei Beatmeten Patienten Unter Therapie Mit Dornase Alfa - Randomisierte, Doppel-Blinde, Placebo-Kontrollierte, Multizentrische, Prospektive Klinische Studie

Last checked: Nov 20, 2026Latest source record: Sep 14, 2006 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 540 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

540

Actual

Start

Aug 2003

Primary completion

Not stated

Study completion Jul 2006

Sponsor

Lead sponsor
University Hospital TuebingenAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Joachim Riethmueller, Dr. med.
First posted
Sep 20, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether Inhalation of Recombinant Human Deoxyribonuclease Shortens Ventilation Time in Mechanically Ventilated Adults

Conditions

  • Long Term Ventilation

Interventions

  • dornase alfaDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time of mechanical ventilation from beginning of the ventilation-therapy up to the end of the ventilation-therapy

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Charité, Universitätsmedizin Berlin, Campus Mitte, Innere Intensivstation

    Berlin, Germany

  • Universität Charité, Campus Mitte, Anästhesie, Intensivstation

    Berlin, Germany

  • Vivantes Klinikum Spandau, Klinik für Anästhesie

    Berlin, Germany

  • Klinikum Chemnitz gGmbH, Innere Medizin

    Chemnitz, Germany

  • Universitätsklinikum Erlangen Medizinische Klinik, Intensivstation I

    Erlangen, Germany

  • Universitätsklinikum, Innere Medizin, Intensivstation

    Frankfurt, Germany

  • Universitätsklinikum Hamburg-Eppendorf, Medizinische Intensivstation

    Hamburg, Germany

  • Medizinische Hochschule Hannover, Anästhesiologie

    Hanover, Germany

  • Anästhesiolog. Klinik der Ruprecht-Karls-Universität

    Heidelberg, Germany

  • Universitätsklinikum des Saarlandes, Innere Medizin III, Internistische Intensivstation

    Homburg / Saar, Germany

  • Klinik für Anästhesiologie u. IntensivtherapieUniversität Leipzig

    Leipzig, Germany

  • Universitätsklinik Lübeck, Medizinische Klinik 1

    Lübeck, Germany

  • Department of internal Medicine

    Lüdenscheid, Germany

  • Universität Magdeburg, Innere Medizin,

    Magdeburg, Germany

  • Gutenberg-Universität, Anästhesie-Intensivstation

    Mainz, Germany

  • Johannes Gutenberg-Universität Mainz, II. Medizinische Klinik, Intensivstation

    Mainz, Germany

  • Johannes-Gutenberg-Universität, Neurochirurgische Klinik

    Mainz, Germany

  • Universitätsklinikum Mannheim, I. Med. Klinik

    Mannheim, Germany

  • Klinikum der Philipps-Universität Marburg, Intensivstation III

    Marburg, Germany

  • Klinikum der Univ. München Großhadern, Anaesthesiologische Intensivstation

    München, Germany

  • Klinikum der Univ. München Großhadern

    München, Germany

  • Ludwig Maximilians Universität München, Großhadern, Neurologie-Intensiv

    München, Germany

  • Berufsgenossenschaftliche Klinik Tuebingen, Intensive care Unit

    Tübingen, Germany

  • Intensive Care Unit of the Internal Department, Universitiy of Tuebingen

    Tübingen, Germany

  • University Hospital, Anaesthesiology

    Tübingen, Baden-Wurttemberg, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.